Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety and efficacy evaluation of Thykamine in adult patients with mild-to-moderate Atopic Dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:24:49.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria such as age, health conditions, and prior treatments.
    Difference
    42%
    Check dated 2024-05-22T20:32:57.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:33:28.000Z thumbnail image

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.